In an interview during the 2018 OncLive® State of the Science Summit™ on Gastrointestinal Malignancies, Becerra, medical oncologist, Texas Oncology, discussed sequencing strategies, immunotherapy, and practice-changing clinical trials in the field of pancreatic cancer. Read more . . .
Emerging data are changing the treatment paradigm in pancreatic cancer, offering patients new options and more personalized care, according to Carlos Becerra, MD.